Subgroup | Value | Reference | Statin | Control | Relative risk (95% CI) | p value | Heterogeneity | p value for heterogeneity |
---|---|---|---|---|---|---|---|---|
 |  |  | (Event/total) | (Event/total) |  |  |  |  |
Mean Age | > = 65 | 24,25 | 76/1425 | 99/1479 | 0.79 [0.59, 1.06] | 0.114 | 0% | 0.81 |
 | <65 | 29, 31, 32,34 | 4/480 | 5/477 | 0.83 [0.24, 2.96] | 0.778 | 0% | 0.53 |
Cardiovascular History | Yes | 29,31,34 | 76/1280 | 98/1230 | 0.80 [0.60, 1.07] | 0.126 | 0% | 0.69 |
 | No | 25,32 | 0/192 | 2/205 | 0.35 [0.04, 3.28] | 0.354 | 0% | 0.96 |
Baseline Creatinine | > = 1.5 | 25,29 | 17/333 | 28/339 | 0.63 [0.35, 1.12] | 0.116 | 0% | 0.68 |
 | <1.5 | 24, 31,32,34 | 63/1572 | 76/1617 | 0.85 [0.62, 1.18] | 0.338 | 0% | 0.94 |
LDL Cholesterol Lowering | > = 30% | 29 | 17/286 | 27/293 | 0.65 [0.36, 1.16] | 0.142 | - | - |
 | <30% | 24,25,32 | 4/625 | 6/636 | 0.75 [0.23, 2.42] | 0.625 | 0% | 0.73 |
Follow-up time | > = 3 | 24, 29,31,32,34 | 80/1858 | 103/1910 | 0.80 [0.60, 1.06] | 0.122 | 0% | 0.90 |
 | <3 | 25 | 0/47 | 1/46 | 0.33 [0.01, 7.81] | 0.489 | - | - |